H2AX and cholangiocarcinoma: Treating CCA cell lines with 200 nm GEM indicated (via γ‐H2AX assay) that CXCL6 knockdown aggravated drug‐induced DNA damage in both HuCCT1 and RBE cells (Figure S4A, Supporting Information).